Blair William & Co. IL Purchases 294 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Blair William & Co. IL boosted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.3% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 110,258 shares of the company’s stock after purchasing an additional 294 shares during the period. Blair William & Co. IL’s holdings in GE HealthCare Technologies were worth $8,591,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. 9258 Wealth Management LLC lifted its position in shares of GE HealthCare Technologies by 5.7% during the 4th quarter. 9258 Wealth Management LLC now owns 3,273 shares of the company’s stock valued at $253,000 after buying an additional 176 shares in the last quarter. Principal Securities Inc. purchased a new position in shares of GE HealthCare Technologies during the 4th quarter valued at $38,000. Gladstone Institutional Advisory LLC boosted its holdings in GE HealthCare Technologies by 27.6% in the 4th quarter. Gladstone Institutional Advisory LLC now owns 3,938 shares of the company’s stock worth $304,000 after buying an additional 851 shares during the period. Coldstream Capital Management Inc. increased its stake in GE HealthCare Technologies by 26.8% in the 4th quarter. Coldstream Capital Management Inc. now owns 4,462 shares of the company’s stock worth $345,000 after buying an additional 942 shares in the last quarter. Finally, Corient Private Wealth LLC raised its holdings in GE HealthCare Technologies by 20.8% during the fourth quarter. Corient Private Wealth LLC now owns 69,073 shares of the company’s stock valued at $5,341,000 after acquiring an additional 11,907 shares during the period. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 0.4 %

GEHC opened at $90.28 on Friday. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.82 and a current ratio of 1.06. The stock’s 50 day moving average price is $83.86 and its 200-day moving average price is $83.36. GE HealthCare Technologies Inc. has a one year low of $62.35 and a one year high of $94.50. The stock has a market cap of $41.21 billion, a price-to-earnings ratio of 26.40, a P/E/G ratio of 3.26 and a beta of 1.17.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share for the quarter, topping the consensus estimate of $0.98 by $0.02. The business had revenue of $4.84 billion during the quarter, compared to the consensus estimate of $4.88 billion. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The business’s revenue for the quarter was up .5% compared to the same quarter last year. During the same period last year, the company earned $0.92 earnings per share. On average, equities analysts forecast that GE HealthCare Technologies Inc. will post 4.26 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be paid a $0.03 dividend. The ex-dividend date is Friday, October 18th. This represents a $0.12 annualized dividend and a yield of 0.13%. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.51%.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the company. Redburn Atlantic raised GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. BTIG Research upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price for the company in a research report on Wednesday. JPMorgan Chase & Co. started coverage on shares of GE HealthCare Technologies in a report on Monday, September 9th. They issued a “neutral” rating and a $90.00 price target on the stock. Stifel Nicolaus began coverage on shares of GE HealthCare Technologies in a report on Tuesday, August 6th. They set a “buy” rating and a $100.00 price objective for the company. Finally, The Goldman Sachs Group began coverage on GE HealthCare Technologies in a report on Thursday, May 30th. They issued a “neutral” rating and a $87.00 target price on the stock. Six investment analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and a consensus target price of $95.00.

Insiders Place Their Bets

In related news, CEO Thomas J. Westrick sold 2,750 shares of GE HealthCare Technologies stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total value of $222,145.00. Following the completion of the sale, the chief executive officer now directly owns 17,509 shares in the company, valued at $1,414,377.02. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.